Home › Funds › Royce & Associates › DORM
Royce & Associates position in DORM
DORMAN PRODUCTS INC · Consumer Discretionary
Royce & Associates reported holding 753,771 shares of DORM (DORMAN PRODUCTS INC) in its Q3 2026 13F filing — a position valued at US$92.4M, representing 0.84% of its reported portfolio and ranking #6 among its reported holdings. Royce & Associates has disclosed DORM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Royce & Associates's DORM position evolved
Royce & Associates first disclosed a stake in DORM in Q3 2021 at 491,584 shares (US$46.5M). The position peaked in Q2 2026 at 824,216 shares, worth US$112.5M. Across 21 filings, Royce & Associates increased the stake 11 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 753,771 shares valued at US$92.4M — a reduction of -70,445 shares quarter over quarter.. Notable position changes include a 34% increase in Q2 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 491.58K | $46.54M | New |
| Q4 2021 | 520.05K | $58.77M | Add |
| Q1 2022 | 563.84K | $53.58M | Add |
| Q2 2022 | 653.93K | $71.74M | Add |
| Q3 2022 | 683.84K | $56.16M | Add |
| Q4 2022 | 597.71K | $48.34K | Reduce |
| Q1 2023 | 613.01K | $52.88K | Add |
| Q2 2023 | 633.20K | $49.92M | Add |
| Q3 2023 | 628.51K | $47.62M | Reduce |
| Q4 2023 | 527.83K | $44.03M | Reduce |
| Q1 2024 | 455.05K | $43.86M | Reduce |
| Q2 2024 | 445.39K | $40.74M | Reduce |
| Q3 2024 | 523.88K | $59.26M | Add |
| Q4 2024 | 509.95K | $66.06M | Reduce |
| Q1 2025 | 486.79K | $58.68M | Reduce |
| Q2 2025 | 493.33K | $60.52M | Add |
| Q3 2025 | 497.42K | $77.54M | Add |
| Q4 2025 | 498.96K | $61.47M | Hold |
| Q1 2026 | 616.66K | $64.35M | Add |
| Q2 2026 | 824.22K | $112.46M | Add |
| Q3 2026 | 753.77K | $92.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DORM and 13F data
DORM (DORMAN PRODUCTS INC) is a Consumer Discretionary company. 31 other funds we track also report a position in DORM — the largest reported positions include KTF INVESTMENTS, LLC (US$106.5M), ROYCE & ASSOCIATES LP (US$92.4M), REINHART PARTNERS, LLC. (US$85.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DORM
- KTF INVESTMENTS, LLC 868.67K sh · $106.50M · Q3 2026
- ROYCE & ASSOCIATES LP 753.77K sh · $92.41M · Q3 2026
- REINHART PARTNERS, LLC. 696.56K sh · $85.40M · Q3 2026
- Channing Capital Management, LLC 637.52K sh · $78.16M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 389.10K sh · $47.70M · Q3 2026
More on Royce & Associates
FAQ
How long has Royce & Associates held DORM?
Royce & Associates has disclosed DORM holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Royce & Associates's current position in DORM?
As of Q3 2026, Royce & Associates holds 753.77K shares of DORM (DORMAN PRODUCTS INC), valued at $92.41M, representing 0.84% of its reported portfolio and ranking #6.
Has Royce & Associates been buying or selling DORM?
In the latest 13F filing (Q3 2026), Royce & Associates reduced its position in DORM. The position peaked in Q2 2026 at 824.22K shares.
Which other funds hold DORM?
Other major institutional holders of DORM include KTF INVESTMENTS, LLC, ROYCE & ASSOCIATES LP, REINHART PARTNERS, LLC., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.